Related Experiment Video
Updated: May 16, 2026
En Face Endocardial Cushion Preparation for Planar Morphogenesis Analysis in Mouse Embryos
Published on: July 27, 2022
Novel roles of PAK1 in the heart
1Department of Physiology and Biophysics and Center for Cardiovascular Research; University of Illinois at Chicago; Chicago, IL USA.
Abstract:
Our work and others' over the past few years have led to the identification of new roles of PAK1 in cardiac physiology, such as the regulation of cardiac ion channel and actomyosin function. More recent studies have revealed that PAK1-deficient mice were vulnerable to cardiac hypertrophy and readily progress to failure under sustained pressure overload and susceptible to ischemia/reperfusion injury. Our further study indicated that the PAK1 activator FTY720 was able to prevent this pressure overload-induced hypertrophy in wild-type mice without compromising their cardiac functions. A cardiac protective effect against ischemia/reperfusion injury by FTY720 was also observed in both rat and mouse models by us and others. Thus, these studies suggest that PAK1 is more important in the heart than previously thought, in particular a therapeutic potential of PAK1 activators. In the future, in-depth investigations are required to further substantiate our hypotheses on mechanisms for PAK1 function in the heart and to explore a therapeutic potential of FTY720 and other PAK1 activators in heart disease conditions.
Insights
p21-activated kinase 1 (PAK1) plays a crucial role in heart function. Activating PAK1 with FTY720 protects against cardiac hypertrophy and injury, suggesting therapeutic potential for heart diseases.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Pharmacology
Background:
- p21-activated kinase 1 (PAK1) regulates cardiac ion channels and actomyosin function.
- PAK1 deficiency in mice leads to cardiac hypertrophy, failure under pressure overload, and susceptibility to ischemia/reperfusion injury.
Purpose of the Study:
- To investigate the role of PAK1 in cardiac physiology and disease.
- To evaluate the therapeutic potential of PAK1 activators, specifically FTY720, in preventing cardiac dysfunction.
Main Methods:
- Utilized PAK1-deficient mice to assess cardiac vulnerability.
- Administered FTY720, a PAK1 activator, to wild-type mice subjected to pressure overload.
- Evaluated cardiac protection against ischemia/reperfusion injury in rat and mouse models.
Main Results:
- FTY720 treatment prevented pressure overload-induced cardiac hypertrophy in wild-type mice without impairing cardiac function.
- FTY720 demonstrated a protective effect against ischemia/reperfusion injury in both rat and mouse models.
Conclusions:
- PAK1 is critically important in cardiac health, with functions extending beyond previously known roles.
- PAK1 activators, such as FTY720, hold significant therapeutic potential for treating heart diseases, including hypertrophy and ischemic injury.
Related Concept Videos
01:09Cytoskeletal Linker Proteins - Plakins
01:27Development of the Heart
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
01:29Pathophysiology of Cardiac Performance
01:28Mechanism of Cardiac Arrhythmias